However, it is reported that promoter methylation of RIZ1, another apoptosis related gene, is not a characteristic feature of advanced CML disease which is in contrast to present findings which could again be attributed to the smaller number of subjects included in the previously reported study [31]. This evidence concerns the gene PRDM2 and chronic myelogenous leukemia, BCR-ABL1 positive.